SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001610717-24-000378
Filing Date
2024-06-28
Accepted
2024-06-28 17:08:29
Documents
1
Period of Report
2024-06-20

Document Format Files

Seq Description Document Type Size
1 form4.html 4/A  
1 form4.xml 4/A 5685
  Complete submission text file 0001610717-24-000378.txt   7111
Mailing Address 700 SAGINAW DR REDWOOD CITY CA 94063
Business Address 700 SAGINAW DR REDWOOD CITY CA 94063 415-766-3638
Revolution Medicines, Inc. (Issuer) CIK: 0001628171 (see all company filings)

IRS No.: 472029180 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O REVOLUTION MEDICINES, INC. 700 SAGINAW DRIVE REDWOOD CITY CA 94063
Business Address
Borellini Flavia (Reporting) CIK: 0001867426 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-39219 | Film No.: 241086776